← Back to catalogue

Perfluoron

FDA UDI

Class III (US FDA UDI)

by Alcon Laboratories, Inc.

Identity

Trade Name
PERFLUORON FDA UDI
Generic Name
Aqueous/vitreous humour replacement medium kit FDA UDI
Device Name
PFNO KIT 5ML<USA Kit Contents: One 5 mL vial of sterile PERFLUORON Liquid One 10 mL syringe One 20 gauge beveled needle One 0.2 micron filter unit One 23 gauge blunt cannula One PERFLUORON Liquid package insert FDA UDI
Model / Reference
0090010015 FDA UDI
Description
PFNO KIT 5ML<USA Kit Contents: One 5 mL vial of sterile PERFLUORON Liquid One 10 mL syringe One 20 gauge beveled needle One 0.2 micron filter unit One 23 gauge blunt cannula One PERFLUORON Liquid package insert FDA UDI

Identifiers

Catalog Number
8065900163 FDA UDI
Primary DI / UDI-DI
00380659001635 FDA UDI
FDA Product Code
LWL FDA UDI
GMDN Term
Aqueous/vitreous humour replacement medium kit FDA UDI

Classification

Device Class
Class III FDA UDI
Regulation Number
886.4275 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 5 Milliliter FDA UDI

Category: Aqueous/vitreous humour replacement medium kit

Perfluoron by Alcon Laboratories, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Aqueous/vitreous humour replacement medium kit.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a4e4c8ad-c906-4a00-815a-3369e876cdcf 36 fields · synced Jun 8, 2026